Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
Furst
D E
DE
University of California, UCLA, Rheumatology, Division Los Angeles, USA. defurst@mednet.ucla.edu
Breedveld
F C
FC
Kalden
J R
JR
Smolen
J S
JS
Burmester
G R
GR
Dougados
M
M
Emery
P
P
Gibofsky
A
A
Kavanaugh
A F
AF
Keystone
E C
EC
Klareskog
L
L
Russell
A S
AS
van de Putte
L B A
LB
Weisman
M H
MH
Kavenaugh
A F
AF
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D007155:Immunologic Factors; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha